A “gold standard” trial found that semaglutide helped reduce drinking in people with obesity who sought out treatment for ...

Once-weekly semaglutide was tied to a reduction in heavy drinking days among adults with obesity and alcohol use disorder, ...

Semaglutide cut heavy drinking days by about 41%, the study found.

Alcoholics given semaglutide reduced alcohol consumption, had fewer heavy drinking days and saw a reduction in alcohol ...

Compared with placebo, semaglutide achieved larger reductions in heavy-drinking days (−41.1 vs −26.4 percentage points) and ...

A trial of 108 adults with obesity seeking treatment for alcohol use finds a once-weekly semaglutide injection reduced heavy ...

‘Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial’ by Mette Kruse Klausen et al. was published in ...

Newleos doses the first participant in a Phase 1b study of NTX-2001, a potential first-in-class TAAR1 partial agonist for ...

Getty Images The limited treatment options available for alcohol use disorder emphasize the urgent need for more research into pharmacological therapies. While more research is needed, preclinical and ...

The FBI director has until April 28 to answer 10 questions about his relationship with alcohol.

Alcohol affects men and women very differently, especially women dependent on alcohol. For five years, the Yale Program on Sex Differences in Alcohol Use Disorder (AUD), headed by Dr. Sherry McKee, ...